SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038606
Filing Date
2020-08-10
Accepted
2020-08-10 07:30:55
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q grtx-10q_20200630.htm 10-Q 1561081
2 EX-4.1 grtx-ex41_65.htm EX-4.1 170347
3 EX-10.1 grtx-ex101_63.htm EX-10.1 76305
4 EX-10.2 grtx-ex102_64.htm EX-10.2 127553
5 EX-31.1 grtx-ex311_7.htm EX-31.1 18118
6 EX-31.2 grtx-ex312_8.htm EX-31.2 19309
7 EX-32.1 grtx-ex321_9.htm EX-32.1 8466
8 EX-32.2 grtx-ex322_6.htm EX-32.2 8271
  Complete submission text file 0001564590-20-038606.txt   5242855

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT grtx-20200630.xml EX-101.INS 900022
10 XBRL TAXONOMY EXTENSION SCHEMA grtx-20200630.xsd EX-101.SCH 37805
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grtx-20200630_cal.xml EX-101.CAL 40673
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grtx-20200630_def.xml EX-101.DEF 85442
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20200630_lab.xml EX-101.LAB 302188
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20200630_pre.xml EX-101.PRE 216256
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 201087090
SIC: 2834 Pharmaceutical Preparations